An investigation into the interrelationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases

Drug Metabolism and Drug Interactions

Volumn 19, Issue 4, 2003, Pages 223-240

  Steventon, Glyn B ^a   Waring, Rosemary H ^b   Williams, Adrian C ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Motor neurone disease; Parkinson's disease; Pharmacogenetics; Sulphur xenobiotic biotransformations

Indexed keywords

ALIPHATIC COMPOUND; CARBOCISTEINE; MERCAPTOETHANOL; PARACETAMOL; PHENOL DERIVATIVE; SULFUR; THIOESTER; THIOL DERIVATIVE; METHYLTRANSFERASE; THIOL METHYLTRANSFERASE; THIOL S-METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DRUG SULFATION; DRUG URINE LEVEL; FEMALE; GENETIC REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOTOR NEURON DISEASE; OXIDATION; PARKINSON DISEASE; PHENOTYPE; RISK FACTOR; URINALYSIS; XENOBIOTIC METABOLISM; BLOOD; ERYTHROCYTE; GENETICS; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; URINE;

ACETAMINOPHEN; ADULT; AGED; AGED, 80 AND OVER; BIOTRANSFORMATION; CARBOCYSTEINE; ERYTHROCYTES; FEMALE; HUMANS; MALE; METHYLATION; METHYLTRANSFERASES; MIDDLE AGED; MOTOR NEURON DISEASE; OXIDATION-REDUCTION; PARKINSON DISEASE; PHENOTYPE; SULFUR;

EID: 1642487769     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2003.19.4.223     Document Type: Article

References (19)

1. Steventon G, Williams AC, Waring RH, Pall HS, Adams D. Xenobiotic metabolism in motorneuron disease. Lancet 1988; ii: 644-647.
2. Steventon GB, Heafield MTE, Waring RH, Williams AC. Xenobiotic metabolism in Parkinson's disease. Neurology 1989; 39: 883-887.
3. Steventon GB, Sturman S, Waring RH, Williams AC. A review of xenobiotic metabolism enzymes in Parkinson's and motor neuron disease. Drug Metab Drug Int 2001; 18: 79-98.
4. Williams AC, Steventon GB, Sturman S, Waring RH. Hereditary variation of liver enzymes involved with detoxification and neurodegenerative disease. J Inherit Metab Dis 1991; 14: 431-435.
5. McFadden SA. Phenotypic variation in xenobiotic metabolism and adverse environmental response: focus on sulfur-dependent detoxification pathways. Toxicology 1996; 111: 43-65.
6. Humfrey CDN, Steventon GB, Sturman SG, Waring RH, Williams AC. Monoamine oxidase substrates in Parkinson's disease. Biochem Pharmacol 1990; 40: 2562-2564.
7. Green S, Buttrum S, Molloy H, Steventon G, Sturman S, Waring R, Pall H, Williams A. N-Methylation of pyridines in Parkinson's disease. Lancet 1991; 338: 120-121.
8. Waring RH, Steventon GB, Sturman SG, Heafield MTE, Smith MCG, Williams AC. S-Methylation in motorneuron disease and Parkinson's disease. Lancet 1989; ii: 356-357.
9. Steventon GB, Heafield MTE, Sturman S, Waring RH, Williams AC. Metabolism of low-dose paracetamol in patients with chronic neurological disease. Xenobiotica 1990; 20: 2562-2564.
10. Waring RH, Mitchell SC, O'Gorman J, Fraser M. Cytosolic sulphoxidation of S-carboxymethyl-L-cysteine in mammals. Biochem Pharmacol 1986; 35: 2999-3002.
11. Weinshilboum RM. Thiopurine phannacogenetics: clinical and molecular studies of thiopurine methyltransferase. Drug Metab Disp 2001; 29: 601-605.
12. Hagata K, Yamazoe Y. Pharmacogenetics of sulfotransferases. Annu Rev Pharmacol Toxicol 2000; 40: 159-176.
13. 13C) analogues. Arch Pharm (Weinheim) 1990; 323: 957-965.
14. Staffeldt B, Brockmoller J, Roots I. Determination of S-carboxymethyl-L-cysteine and some of its metabolites in urine and serum by high-performance liquid chromatography using fluorescent pre-column labelling. J Chromatogr 1991; 571: 133-147.
15. Weinshilboum RM, Sladek S, Klumpp S. Human erythrocyte thiol methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 1979; 97: 59-71.
16. Mitchell SC, Waring RH, Haley CS, Idle JR, Smith RL. Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Br J Clin Pharmacol 1984; 18: 507-521.
17. Keith RA, Van Loon J, Wusson LF, Weinshilboum RM. Thiol methylation pharmacogenetics: heritability of human erythrocyte thiol methyltransferase activity. Clin Pharm Ther 1983; 34: 521-528.
18. Steventon G, Waring R, Sturman S, Heafield MTE, Williams AC. The metabolism of S-carboxymethyl-L-cysteine in man. A neurodegenerative disease study. Med Sci Res 1999; 27: 119-120.
19. Peters L, Steventon GB, Green S, Sturman S, Waring RH, Williams AC. D-Penicillamine metabolism in neurodegenerative disease: an in vivo/in vitro sulphydryl methylation study. Xenobiotica 1994; 24: 1013-1020.